Transforming Bladder Cancer Treatment with BioXmark Liquid Fiducial Marker Technology

Understanding Bladder Cancer and the Need for Precision
Bladder cancer, particularly muscle-invasive types, can be challenging to manage due to the delicate and dynamic nature of the bladder. Treatments like radiation therapy require pinpoint accuracy to target tumors while preserving healthy tissue. This is where advancements in technology, such as fiducial markers, play a crucial role.

Fiducial markers are used as reference points in image-guided radiation therapy (IGRT). They allow clinicians to visualize and track the target area with unparalleled accuracy. Among the latest innovations, BioXmark has emerged as a groundbreaking liquid fiducial marker solution tailored to meet these challenges head-on.
 

What Makes BioXmark a Game-Changer?
BioXmark is a liquid fiducial marker specifically designed to provide flexibility and accuracy in radiation therapy planning. Its features include:

1. Customizable Implantation for Seamless Precision

Unlike traditional markers, BioXmark is liquid-based. This allows clinicians to implant multiple markers of varying sizes during a single, uninterrupted procedure. The markers quickly adapt to surrounding tissue, ensuring they remain securely in place throughout radiation therapy.
 

2. Exceptional Visibility Across Imaging Modalities

BioXmark stands out for its compatibility with both CT and MRI imaging. Its clear visibility and positional stability enable accurate treatment planning, even for advanced therapies like proton therapy.

Dr. Christopher Saigal, a leading urologist, highlights its impact, stating, “By using BioXmark, we can clearly outline treatment areas on CT imaging. This allows us to deliver therapy with greater precision, ensuring better-targeted treatments for the patient.”
 

3. Enhanced Workflow Efficiency

BioXmark requires minimal equipment and integrates seamlessly with existing clinical workflows, enabling care teams to focus more on the patient.
 

4. Safe and Controlled Application

According to a study published in the British Journal of Radiology³, BioXmark offers sustained visibility and positional stability during treatment phases. The study, which included 20 patients with muscle-invasive bladder cancer, demonstrated:

• Visibility of the markers in 79% of cases, surpassing the predefined benchmark of 75%.
• Improved success rates over time, emphasizing the ease of mastering its application.
• No BioXmark-related adverse events, confirming its safety profile.

5. Versatile and FDA-Cleared for Multiple Indications

BioXmark is cleared by the FDA for radiographic marking of the bladder, lung, and lymph nodes in adult patients. This versatility underscores its potential to address the varied challenges faced by medical professionals across specialties.

Real Stories of Impact
Clinicians using BioXmark have observed significant improvements in care delivery. Dr. Saigal recounts a particularly impactful case involving a patient choosing a bladder-sparing protocol after tumor resection. “BioXmark transformed the way we approached post-surgical care and radiation therapy. Its precision and simplicity are remarkable. The Radiation Oncologist was also impressed with the imaging quality and the ability to accurately pinpoint the markers.” he shared.
 

Broader Implications for Bladder Cancer Care
Innovative tools like BioXmark align with the growing trend of bladder-preserving treatments. These approaches, which combine surgery, chemotherapy, and radiation therapy, offer new hope to patients seeking alternatives to radical cystectomy. Technology that enhances precision and efficiency, such as liquid fiducial markers, is essential for advancing these protocols.
 

Benefits for Patients
For many patients, precision translates directly to better outcomes. Tools like BioXmark liquid fiducial markers reduce the risk of damage to healthy tissue, minimize side effects, and help maintain quality of life. For those undergoing bladder-sparing treatments, the peace of mind that comes with highly targeted therapy cannot be overstated.
 

Benefits for Clinicians
By simplifying workflows and improving accuracy, BioXmark enables clinicians to focus on what truly matters—providing compassionate and effective care. It supports their efforts to stay at the forefront of patient-centered, cutting-edge medicine.


Why BioXmark Matters for Medical Professionals
Bladder cancer treatment requires balancing empathy with technical precision. BioXmark exemplifies this harmony. It empowers doctors to offer treatments that are not only innovative but also thoughtfully designed with the patient’s experience in mind.

Whether you're a Radiation Oncologist, Medical Physicist, or Urologist, tools like BioXmark can transform how you approach bladder cancer care. Imagine being able to deliver adaptive IGRT with unshakable confidence in your imaging and treatment accuracy. That’s the potential of this groundbreaking technology.

Take the Next Step Towards Smarter Bladder Cancer Care
The future of bladder cancer treatment is here, and it’s defined by innovation, precision, and compassion. If you’re ready to elevate your practice and ensure better outcomes for your patients, now is the time to explore BioXmark.

• Discover how BioXmark can revolutionize your approach to bladder cancer treatment.
• For immediate access to CQ Medical’s Solution Spotlight webinar featuring BioXmark, request access now!

Request a Free Sample 

References
1. American Cancer Society. Key Statistics for Bladder Cancer. Accessed May 19, 2025. https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy
2. American Cancer Society. Incidence and Mortality Rates for Urinary Bladder Cancer Over Time. Accessed May 19, 2025. https://cancerstatisticscenter.cancer.org/types/urinary-bladder
3. de Ridder M, Gerbrandy LC, de Reijke TM, Hinnen KA, Hulshof MCCM. BioXmark liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial. Br J Radiol. 2020 Jul;93(1111):20200241. doi:10.1259/bjr.20200241.

Copyright ©2025 CQ Medical. All rights reserved. CQ Medical and BioXmark are registered trademarks of CQ Medical. All product may not be licensed in accordance with Canadian law. CQ2025D42 Rev. 0